PSMA-T4 kit for Tc-99m labelling
Sponsors
Narodowe Centrum Badan Jadrowych
Conditions
Feasibility analysis and safety evaluation of [99mTc]Tc-PSMA-T4 in prostate cancer diagnosis and treatment planning.triple-negative breast cancer
Phase 2
An open-label phase 2/3 study to analyse the feasibility and evaluate the safety of intravenous administration of 99mTc-PSMA-T4 in patients with prostate cancer
Not yet recruitingCTIS2024-519358-35-00
Target: 80Updated: 2025-01-29
Prognostic value assessment of PSMA-T4 examination in the group of patients with triple-negative breast cancer (TNBC) qualified to radical therapy
Not yet recruitingCTIS2025-525110-29-01
Target: 100Updated: 2026-08-12